09/03/2026
Fresenius Kabi, part of the Fresenius Group, has launched FDA‑approved generic Sugammadex Injection, providing hospitals and surgical teams with new options. The product is available in our Simplist® ready‑to‑administer prefilled syringe—helping support flexibility and efficient workflows.
Fresenius Kabi is committed to strengthening healthcare resilience through reliable access to high-quality essential medicines. The launch of Sugammadex further enhances the company’s U.S. pharmaceutical portfolio and supports healthcare providers in delivering safe and effective patient care.
This launch also reflects our More in America commitment. Our Sugammadex products are filled, formulated, and packaged in the U.S. to help strengthen supply chain resilience and support reliable access for patients and providers.
Learn more about this new offering: https://www.fresenius-kabi.com/us/news-and-events/simplist-rta-generic-sugammadex-syringe